학술논문
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis
Document Type
Article
Author
Source
In Brain Behavior and Immunity January 2014 35:176-181
Subject
Language
ISSN
0889-1591